NEUROGESX, INC. RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 26th, 2009 • NeurogesX Inc • Pharmaceutical preparations • Delaware
This Restated Executive Employment Agreement (the “Agreement”) is made and entered into by and between Russell Kawahata (the “Executive”) and NeurogesX, Inc., a Delaware Corporation (the “Company”), effective as of December 31, 2008 (the “Effective Date”).
COMMERCIAL SUPPLY AND LICENSE AGREEMENTCommercial Supply and License Agreement • March 26th, 2009 • NeurogesX Inc • Pharmaceutical preparations
This COMMERCIAL SUPPLY AND LICENSE AGREEMENT (this “Agreement”), is entered into as of day of January, 2007 (“Effective Date”) by and between
EXCLUSIVE LICENSE AGREEMENT between THE REGENTS OF THE UNIVERSITY OF CALIFORNIA and NEUROGESX, INC. for HIGH DOSE CAPSAICIN FOR NEUROPATHIC PAIN UCSF Case No. SF00-056Exclusive License Agreement • March 26th, 2009 • NeurogesX Inc • Pharmaceutical preparations • California
This license agreement (the “Agreement”) is made effective November 1, 2000 (the “Effective Date”) between THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, a California corporation having its statewide administrative offices at 1111 Franklin Street, Oakland, California 94607-5200, (“The Regents”), and acting through its Office of Technology Management, University of California San Francisco, 1294 Ninth Avenue – Suite 1, Box 1209, San Francisco, CA 94143-1209 (“UCSF”), and NEUROGESX, INC., a Delaware corporation having a principal place of business at 2215 Bridgepointe Parkway, Suite 200, San Mateo, California, (the “Licensee”).
